Molecular chaperones (TrxA, SUMO, Intein, and GST) mediating expression, purification, and antimicrobial activity assays of plectasin in Escherichia coli

被引:30
作者
Chen, Xin [1 ]
Shi, Jiawei [2 ]
Chen, Rui [3 ]
Wen, Yaoan [2 ]
Shi, Yu [4 ]
Zhu, Zhe [1 ]
Guo, Songwen [1 ]
Li, Ling [4 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Dept Resp Med, Guangzhou 510282, Guangdong, Peoples R China
[2] Southern Med Univ, Clin Med Coll 1, Nanfang Hosp, Guangzhou 510282, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Resp Dis, Guangzhou 510275, Guangdong, Peoples R China
[4] Southern Med Univ, Sch Publ Hlth & Trop Med, Biosafety Level Lab 3, Guangzhou 510282, Guangdong, Peoples R China
关键词
cleavage; expression; molecular chaperone; plectasin; purification; RESISTANT STAPHYLOCOCCUS-AUREUS; THIOREDOXIN REDUCTASE; PICHIA-PASTORIS; PEPTIDE; NZ2114;
D O I
10.1002/bab.1303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plectasin (PS) is the first defensin to be isolated from a fungus, the saprophytic ascomycete Pseudoplectania nigrella, and active against Streptococcus pneumoniae and S. aureus, including antibiotic-resistant pathogens. To establish a bacterium-based production system, we compared the efficiency of four molecular chaperones and corresponding cleavage to the expression and purification of plectasin. The results showed that the yield of plectasin combined with thioredoxin A (TrxA) and small ubiquitin-related modifier (SUMO) was at a higher level (0.0356 and 0.0358 g L-1, respectively) than that with intein (0.0238 g L-1) and glutathione-S-transferase (GST) (0.0243 g L-1). TrxA-plectasin, SUMO-plectasin, and 2-plectasin were cleaved at the correct site and purified, but their considerable amount was not cleaved and remained as a fusion peptide. The antimicrobial activity of plectasin cleaved from SUMOplectasin against methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant S. pneumoniae (PRSP), and vancomycin-resistant enterococci (VRE)was stronger than ampicillin (Amp) for the same amount of substance (P 0.05). This is the first study to complete and compare the effect of different molecular chaperones and corresponding cleavage with the expression and purification of plectasin in the Escherichia coli expression system, which laid the foundation for future research and may develop the application and production of plectasin. (C) 2014 International Union of Biochemistry and Molecular Biology, Inc.
引用
收藏
页码:606 / 614
页数:9
相关论文
共 24 条
  • [1] In Vivo Pharmacodynamic Characterization of a Novel Plectasin Antibiotic, NZ2114, in a Murine Infection Model
    Andes, D.
    Craig, W.
    Nielsen, L. A.
    Kristensen, H. H.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) : 3003 - 3009
  • [2] Plectasin Shows Intracellular Activity against Staphylococcus aureus in Human THP-1 Monocytes and in a Mouse Peritonitis Model
    Brinch, Karoline Sidelmann
    Sandberg, Anne
    Baudoux, Pierre
    Van Bambeke, Francoise
    Tulkens, Paul M.
    Frimodt-Moller, Niels
    Hoiby, Niels
    Kristensen, Hans-Henrik
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4801 - 4808
  • [3] Influence of Antidrug Antibodies on Plectasin Efficacy and Pharmacokinetics
    Brinch, Karoline Sidelmann
    Frimodt-Moller, Niels
    Hoiby, Niels
    Kristensen, Hans-Henrik
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4794 - 4800
  • [4] Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression
    Gottlieb, Caroline Trebbien
    Thomsen, Line Elnif
    Ingmer, Hanne
    Mygind, Per Holse
    Kristensen, Hans-Henrik
    Gram, Lone
    [J]. BMC MICROBIOLOGY, 2008, 8 (1)
  • [5] Plectasin has antibacterial activity and no affect on cell viability or IL-8 production
    Hara, Shintaro
    Mukae, Hiroshi
    Sakamoto, Noriho
    Ishimoto, Hiroshi
    Amenomori, Misato
    Fujita, Hanako
    Ishimatsu, Yuji
    Yanagihara, Katsunori
    Kohno, Shigeru
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 374 (04) : 709 - 713
  • [6] Peptide antimicrobial agents
    Jenssen, Havard
    Hamill, Pamela
    Hancock, Robert E. W.
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2006, 19 (03) : 491 - +
  • [7] High-Level Expression of the Antimicrobial Peptide Plectasin in Escherichia coli
    Jing, Xiao-Lan
    Luo, Xue-Gang
    Tian, Wen-Jing
    Lv, Li-Hui
    Jiang, Yong
    Wang, Nan
    Zhang, Tong-Cun
    [J]. CURRENT MICROBIOLOGY, 2010, 61 (03) : 197 - 202
  • [8] [梁文 Liang Wen], 2013, [中国医药工业杂志, Chinese Journal of Pharmaceuticals], V44, P21
  • [9] Nasal carriage of Staphylococcus aureus and methicillin-resistant S aureus in the United States, 2001-2002
    Mainous, AG
    Hueston, WJ
    Everett, CJ
    Diaz, VA
    [J]. ANNALS OF FAMILY MEDICINE, 2006, 4 (02) : 132 - 137
  • [10] Racemic crystallography of synthetic protein enantiomers used to determine the X-ray structure of plectasin by direct methods
    Mandal, Kalyaneswar
    Pentelute, Brad L.
    Tereshko, Valentina
    Thammavongsa, Vilasak
    Schneewind, Olaf
    Kossiakoff, Anthony A.
    Kent, Stephen B. H.
    [J]. PROTEIN SCIENCE, 2009, 18 (06) : 1146 - 1154